Results 131 to 140 of about 62,260 (164)

Six-minute walk distance predicting the risk of mortality in lymphangioleiomyomatosis patients. [PDF]

Orphanet J Rare Dis
Yang L, Zhang X, Wang L, Cheng C, Wang H, Zhang M, Liu S, Xu W, Liu J, Dai J, Meng S, Yang Y, Wang ST, Tian X, Xu KF.   +14 more
europepmc   +1 more source

Neonatal Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon Presenting as Severe Airway Obstruction at Birth: A Case Report. [PDF]

Children (Basel)
Shin S, Shim YJ.
europepmc   +1 more source

A prospective randomized open-label trial of sirolimus versus paclitaxel-coated balloons for the side branch of <i>de novo</i> coronary bifurcation lesion. [PDF]

J Thorac Dis
Gao Q, Liu C, Xu G, Peng X, Chen X, Song X, Jing R, Sang H, Jiang H, Yuan Z, Zhao R, Li C, Xu Q.   +12 more
europepmc   +1 more source

Rescue of Angiopoietin-2 Inhibits Proliferation of Lymphatic Malformation Endothelial Cells. [PDF]

FASEB J
Sun RW, Zhang H, Mehdi SJ, Bowen JK, Burnett AK, Richter GT, Washam CL, Byrum SD, Wu JK, Shawber CJ, Strub GM.   +10 more
europepmc   +1 more source

Retroperitoneal malignant PEComa: a case report. [PDF]

Proc (Bayl Univ Med Cent)
McKenzie A, Cherradi R, Ahmad M, Alameddine R, Olascoaga J, Alani A.   +5 more
europepmc   +1 more source

Sirolimus for Recurrent Chylothorax and Edema in an Infant with Noonan Syndrome after Resolved Hydrops Fetalis: A Case Report. [PDF]

AJP Rep
Hattori M, Tamai K, Watanabe H, Takeuchi A, Nakamura M, Ozeki M, Kageyama M.   +6 more
europepmc   +1 more source

Corticosteroid-to-sirolimus sequential therapy: a case series of infantile kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon. [PDF]

Transl Pediatr
Tan X, Liu Z, Chen K, Zhang M, Xia J, Niu C, Li H.   +6 more
europepmc   +1 more source

Use of Sirolimus, an mTOR Inhibitor, to Treat Sarcoidosis in Multiple Systems. [PDF]

J Cardiovasc Transl Res
McGuire L, Brown R, Asimaki A.
europepmc   +1 more source

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for Infection. [PDF]

Open Forum Infect Dis
Pernikoff S, Clurman A, Rötepohl M, Galanter N, Bibby M, Harris E, Stevens-Ayers T, Xie H, Ueda Oshima M, Cheng GS, Englund JA, Boeckh MJ, Boonyaratanakornkit J.   +12 more
europepmc   +1 more source

Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy. [PDF]

World J Cardiol
Trehan VK, Safal S, Trehan S, Kathuria S, Vani PS.   +4 more
europepmc   +1 more source